| Literature DB >> 29939018 |
Jessica L Counihan1, Elizabeth A Grossman1, Daniel K Nomura1.
Abstract
Dysregulation of cancer cell metabolism contributes to abnormal cell growth, the biological end point of cancer. We review here numerous affected oncogenes and metabolic pathways common in cancer and how they contribute to cancer pathogenesis and malignancy. This review also discusses various pharmacological manipulations that take advantage of these metabolic abnormalities and the current targeted therapies that have arisen from this research.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29939018 DOI: 10.1021/acs.chemrev.7b00775
Source DB: PubMed Journal: Chem Rev ISSN: 0009-2665 Impact factor: 60.622